Form 4: Elevance Health Director Robert L. Dixon Jr. Reports Acquisition of Deferred Stock Units

Director Robert L. Dixon Jr. reports acquisition of deferred stock units in Elevance Health, Inc.

Summary

• Robert L. Dixon Jr., a director of Elevance Health, Inc., reported the acquisition of 388 deferred stock units on May 15, 2024.
• These units were accrued under the company's Board of Directors Compensation Program.
• The deferred stock units will be payable in company common stock upon the earlier of (a) five years from the grant date or (b) the date Dixon ceases to be a member of the board, unless a later date is designated.
• Following the transaction, Dixon beneficially owns 10,026 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation practices and increased ownership, indicating confidence in the company.

Future Outlook

The deferred stock units will be converted to common stock in the future, either five years from the grant date or upon Dixon's departure from the board, unless a later date is designated.

Industry Context

This filing is a routine disclosure related to director compensation and stock ownership, common in publicly traded companies like Elevance Health.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with company performance.

Key Dates